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HIV rapid testing as a key 
strategy for prevention of 
mother-to-child transmission in 
Brazil
Teste rápido para o HIV como 
estratégia de prevenção da 
transmissão vertical no Brasil
ABSTRACT
OBJECTIVE: To assess the feasibility of HIV rapid testing for pregnant women 
at maternity hospital admission and of subsequent interventions to reduce 
perinatal HIV transmission.
METHODS: Study based on a convenience sample of women unaware of 
their HIV serostatus when they were admitted to delivery in public maternity 
hospitals in Rio de Janeiro and Porto Alegre, Brazil, between March 2000 and 
April 2002. Women were counseled and tested using the Determine HIV1/2 
Rapid Test. HIV infection was confi rmed using the Brazilian algorithm for HIV 
infection diagnosis. In utero transmission of HIV was determined using HIV-
DNA-PCR. There were performed descriptive analyses of sociodemographic 
data, number of previous pregnancies and abortions, number of prenatal care 
visits, timing of HIV testing, HIV rapid test result, neonatal and mother-to-
child transmission interventions, by city studied.
RESULTS: HIV prevalence in women was 6.5% (N=1,439) in Porto Alegre 
and 1.3% (N=3.778) in Rio de Janeiro. In Porto Alegre most of women were 
tested during labor (88.7%), while in Rio de Janeiro most were tested in the 
postpartum (67.5%). One hundred and forty-four infants were born to 143 HIV-
infected women. All newborns but one in each city received at least prophylaxis 
with oral zidovudine. It was possible to completely avoid newborn exposure 
to breast milk in 96.8% and 51.1% of the cases in Porto Alegre and Rio de 
Janeiro, respectively. Injectable intravenous zidovudine was administered 
during labor to 68.8% and 27.7% newborns in Porto Alegre and Rio de Janeiro, 
respectively. Among those from whom blood samples were collected within 
48 hours of birth, in utero transmission of HIV was confi rmed in 4 cases in 
Rio de Janeiro (4/47) and 6 cases in Porto Alegre (6/79).
CONCLUSIONS: The strategy proved feasible in maternity hospitals in Rio 
de Janeiro and Porto Alegre. Efforts must be taken to maximize HIV testing 
during labor. There is a need of strong social support to provide this population 
access to health care services after hospital discharge.
DESCRIPTORS: Pregnant Women. Prenatal Care. Breast Feeding. 
AIDS Serodiagnosis. HIV Infections, diagnosis. Infectious Disease 
Transmission, Vertical. Acquired Immunodefi ciency Syndrome, 
prevention & control.
Artigos Originais
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The prevention of mother-to-child transmission 
(PMTCT) has been a major successful public health 
effort to prevent HIV infection in developed coun-
tries. The use of highly active antiretroviral therapy 
(HAART) regimens during pregnancy for PMTCT, 
along with scheduled cesarean delivery and breas-
tfeeding avoidance, have reduced HIV transmission 
rates to under 2%.4
In developing countries, where the HIV impact is 
greatest, success has been limited not only by the cost 
involved on universal implementation of these inter-
ventions, but also by the weakness of health systems.6 
RESUMO
OBJETIVO: Analisar a viabilidade da testagem rápida para o HIV entre 
gestantes na admissão à maternidade e de intervenções para reduzir a 
transmissão perinatal do HIV.
MÉTODOS: Amostra de conveniência de mulheres que desconheciam sua 
situação sorológica para o HIV quando admitidas para o parto em maternidades 
públicas do Rio de Janeiro, RJ, e de Porto Alegre, RS, entre março de 2000 
e abril de 2002. As mulheres foram aconselhadas e testadas com teste rápido 
Determine HIV1/2 na maternidade. Infecção pelo HIV foi confi rmada pelo 
algoritmo brasileiro para o diagnóstico da infecção pelo HIV. A transmissão 
intra-útero foi determinada pelo PCR-DNA-HIV. Foram realizadas análises 
descritivas dos dados sociodemográfi cos, número de gestações e de abortos 
prévios, número de visitas de pré-natal, momento da testagem para o HIV, 
resultado do teste rápido para o HIV, intervenções recebidas pelos recém-natos 
e de transmissão vertical do HIV, de acordo com cada cidade.
RESULTADOS: A prevalência de HIV entre as mulheres foi 6,5% (N=1.439) 
em Porto Alegre e 1,3% (N=3.778) no Rio de Janeiro. A maioria foi testada 
durante o trabalho de parto em Porto Alegre e no pós-parto, no Rio de Janeiro. 
Cento e quarenta e quatro crianças nasceram de 143 mulheres infectadas pelo 
HIV. Todos os recém-natos receberam ao menos a profi laxia com zidovudina 
oral, exceto um em cada cidade. Foi possível evitar qualquer exposição ao 
leite materno em 96,8% e 51,1% dos recém-natos em Porto Alegre e no Rio 
de Janeiro, respectivamente. A zidovudina injetável foi administrada durante 
o trabalho de parto para 68,8% dos recém-natos em Porto Alegre e 27,7% no 
Rio de Janeiro. Entre aqueles com amostras de sangue coletadas até 48 horas 
do nascimento, a transmissão intra-útero foi confi rmada em quatro casos no 
Rio de Janeiro (4/47) e em seis casos em Porto Alegre (6/79).
CONCLUSÕES: A estratégia mostrou-se factível nas maternidades do Rio de 
Janeiro e de Porto Alegre. Esforços devem ser empreendidos para maximizar a 
testagem durante o trabalho de parto. Forte suporte social precisa ser acoplado 
a essa estratégia para garantir o acesso dessa população ao sistema de saúde 
após a alta da maternidade.
DESCRITORES: Gestantes. Cuidado Pré-Natal. Aleitamento Materno. 
Sorodiagnóstico da AIDS. Infecções por HIV, diagnóstico. Transmissão 
Vertical de Doença Infecciosa. Síndrome de Imunodefi ciência 
Adquirida, prevenção & controle.
INTRODUCTION
Brazil was the fi rst developing country to implement 
a countrywide program to prevent HIV vertical trans-
mission. HIV counseling and testing, HAART and 
infant formula are provided free of charge to patients.21 
Although signifi cant progress in reducing HIV mother-
to-child transmission (MTCT) has been seen in Brazil,7 
a signifi cant number of new HIV cases among infants 
continue to occur yearly. Women are either not tested 
during pregnancy or results are not available by the time 
of delivery.20 Rapid assays emerged to meet the demand 
where HIV testing is the main barrier to PMTCT.15
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a Ministério da Saúde. Pesquisa Nacional de Demografi a e da Saúde da Criança e da Mulher. Brasília; 2008.
b Ministério da Saúde. Departamento de Vigilância em Saúde. Programa nacional de DST/AIDS. Recomendações para a prevenção da 
transmissão vertical do HIV e tratamento antiretroviral para gestantes. Brasília; 2006.
In Brazil, over 95% of women give birth in hospitals,a 
creating a key opportunity for systematic offering of 
HIV rapid testing, and other PMTCT interventions. 
The objective of the present study was to assess the 
feasibility of HIV rapid testing for pregnant women at 
maternity hospital admission and of interventions to 
reduce perinatal HIV transmission.
METHODS
We conducted a cross-sectional study. The study 
population was a convenience sample of women with 
unknown HIV serostatus, admitted for delivery in 
middle- and high-complexity maternity departments 
of charity or state-run hospitals in the metropolitan 
areas of Rio de Janeiro (RJ) and Porto Alegre (POA), 
Southeastern and Southern Brazil, respectively. The 
study was conducted between March 2000 and April 
2002. The study sites in the city of POA started the 
study on May 2001.
The inclusion criteria included: unknown HIV serostatus 
(not tested in the current pregnancy or tested but women 
were not aware of the test result) by the time of admis-
sion for delivery; and signed informed consent. Women 
younger than 18 years old, not married or living with a 
partner or whose parents could not provide an informed 
consent for their participation were excluded as well as 
those with any clinical condition that could prevent them 
from being interviewed. Liveborn infants delivered by 
women found to be HIV infected were enrolled.
Women admitted were approached before delivery or 
in the postpartum. The underlying reasons for ineligi-
bility or for refusing to participate were recorded in a 
contact form.
Women were informed that, although a positive result 
in the rapid testing would not be a fi nal diagnosis, 
PMTCT intervention (intravenous AZT, oral AZT and 
infant formula feeding) would be provided following 
the Brazilian Ministry of Health guidelines.b
Women were counseled and tested on-site using the 
Determine HIV 1/2 Rapid Test (Abbott, Chicago, 
IL, USA) on whole blood. All positive results were 
confi rmed by local laboratories following the Brazilian 
Ministry of Health algorithm for HIV diagnosis (HIV-1 
EIA followed by HIV indirect immunofl uorescence or 
HIV Western blot assay). Women with positive test 
results were seen once by a study team member in the 
postpartum and referred to HIV/AIDS specialized care 
in reference centers. At discharge, study outpatient 
visits were scheduled at one, three and six months for 
infants born to these women.
For infant’s HIV diagnosis, blood samples were 
collected within 48 hours of birth and during study 
visits. HIV-1 infection in infants was defi ned as the 
detection of HIV DNA by polymerase chain reaction 
(PCR) on two peripheral blood samples collected in 
different visits or the development of AIDS or death 
from an HIV-1-related cause. A child was classifi ed as 
HIV-1 uninfected if he or she was PCR negative on 
at least two occasions (with the second sample being 
obtained at three months of age or later). Infants with a 
positive DNA PCR in the blood sample collected within 
48 hours of birth were defi ned as in utero-infected.2 For 
children who missed study visits, serology data were 
retrospectively collected and persistence or absence of 
antibody to HIV-1 beyond 18 months was considered 
for the determination of HIV infection status.
Sociodemographic, reproductive and prenatal care 
data were collected by trained interviewers through 
of a structured questionnaire. All forms were piloted 
in the fi eld by at least one member of local study 
teams. Complementary clinical and laboratory data 
were obtained from women’s and infant’s charts. 
Ethnicity/skin color was classifi ed by the interviewers. 
The EpiInfo software 6.04 version was used to create 
study forms, enter data and minimize errors in data 
entry process. Data analysis was performed using the 
Statistical Package for Social Sciences (SPSS), version 
7.0 for Windows.
Descriptive statistics were generated for all variables: 
age, schooling, skin color/ethnicity, family income, 
number of prenatal care visits, number of previous 
pregnancies and abortions, timing of HIV testing, HIV 
rapid test results, PMTCT intervention (intravenous 
AZT, oral AZT and infant formula feeding) and HIV 
MTCT. Mean (standard deviation, SD) and median 
(interquartile interval, IQI) were used to describe conti-
nuous variables. Contingency table statistics were used 
to verify non-homogeneity of proportions to compare 
women’s sociodemographic, reproductive characteris-
tics and prenatal care use in RJ and POA.
In RJ and POA, 23,360 women were contacted; of them, 
73.5% and 74.1%, respectively, were tested during 
the current pregnancy and were unaware of their HIV 
serostatus. Among pregnant women with unknown HIV 
serostatus at delivery, 3.3% in RJ (4,347) and 0.3% in 
POA (1,794) refused to participate in this study. Other 
reasons for exclusion are presented in the Figure.
The study protocol was approved by Institutional 
Review Boards of each maternity hospital and by 
the National Research Ethics Committee (CONEP) 
(Process Nr. 25000.002537/99-67; Approval date 
02/26/1999).
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RESULTS
Table 1 shows sociodemographic, reproductive and 
prenatal characteristics of pregnant women studied. 
Mean age was 24.6 (SD=6.5) and median age was 23 
(IQI: 12;47). Overall, 82.6% of the women had eight 
or less years of schooling.
About 60.0% of women were white in POA, and 
70.0% were black or mixed ethnicity in RJ (p=0.000). 
Mean and median family income in Brazilian monthly 
minimum wages (BMMWs) in the last month was 2.5 
(SD=2.3) and 2.0 (IQI: 0;60) in RJ and 2.6 (SD= 2.4) 
and 2.0 (IQI: 0;40) in POA. Family income up to one 
BMMW in the last month was reported by 30.3% of 
the women.
The proportion of women who did not attend prenatal 
care visits was higher in POA than in RJ. In RJ, women 
attended a higher number of prenatal visits compared 
to those in POA. Mean and median number of prenatal 
visits in RJ was 3.8 (SD=3.0) and 4.0 (IQI= 0;22) and 
in POA 2.9 (SD=3.1) and 2.0 (IQI: 0;23).
Mean and median number of previous pregnancies was 
2.8 (SD=1.9) and 3.3 (SD=2.1) in RJ and 2.0 (IQI: 1;15) 
and 3.0 (IQI: 1;13) in POA; 27.8% of women in RJ and 
18.6% in POA were primiparous.
The proportion of women who reported at least 
one abortion was 23.6% in RJ and 18% in POA 
(p=0.001).
In RJ, 67.5% of women were tested in the postpartum 
period, while in POA, 88.7% were tested during labor 
(p=0.000). HIV infection was diagnosed in 6.5% 
and 1.3% of women in POA and in RJ, respectively 
(p=0.000). One hundred and forty-two singletons and 
a pair of twins were born to 143 HIV-infected women. 
One stillbirth and one newborn died within a few 
minutes after birth and were not considered for the 
description of PMTCT interventions in RJ.
Figure. Study population for HIV rapid testing and perinatal intervention in Brazil. Cities of Rio de Janeiro and Porto Alegre, 
Southeastern and Southern Brazil, 2000–2002.
Total number women contacted
N= 23,360
Women contacted in Rio de Janeiro
n = 16,424
Pregnant women with unknown 
HIV serostatus at delivery
n = 4,347
Number of pregnant women enrolled
 (Rio de Janeiro) n= 3,778
Number of pregnant women enrolled
 (Porto Alegre) n= 1,439
Pregnant women excluded
Rio de Janeiro
n = 569/4,347 (13.1%)
1 - Younger than 18 years old, not legally 
married, not emancipated or without a legal 
representative consent: n = 230 (5.3%)
2 - Factors related to the mother’s health:
n = 135 (3.1%)
3 - Factors related to the newborn’s health:
n = 1 (0.002%)
4 - Confidentiality issues: n = 4 (0.1%)
5 - Refusal to participate: n = 145 (3.3%) 
6 - Not specified: n = 54 (1.2%)
Pregnant women excluded
Porto Alegre
n = 355/1,794 (19.8%)
1 - Younger than 18 years old, not legally married, 
not emancipated or without a legal representa-
tive consent: n = 156 (8.7%)
2 - Factors related to the mother’s health:
n = 16 (0.9%)
3 - Factors related to the newborn’s health:
n = 20 (1.1%)
4 - Confidentiality issues: 0 (0.0%)
5 - Refusal to participate: n = 5 (0.3%) 
6 - Not specified: n = 158 (8.8%)
Pregnant women with unknown 
HIV serostatus at delivery
n = 1,794
Women contacted in Porto Alegre
n = 6,936
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Table 1. Sociodemographic, reproductive and prenatal care characteristics of the study participants. Cities of Rio de Janeiro 
and Porto Alegre, Southeastern and Southern Brazil, 2000–2002.
Variable
Rio de Janeiro 
(n = 3,778)
Porto Alegre
(n = 1,439)
Total
(n = 5,217) p-value
n % n % n %
Age (years)
< 20 987 26.1 295 20.5 1,282 24.6 0.000
20–24 1,260 33.4 458 31.8 1,718 32.9
25–29 736 19.5 302 21.0 1,038 19.9
30–34 433 11.4 204 14.2 637 12.2
≥ 35 351 9.3 159 11.0 510 9.8
Missing information 11 0.3 21 1.5 32 0.6
Schooling (years)
≤ 4 1,224 32.4 461 32.0 1,685 32.3 0.183
5–8 1,879 49.7 746 51.9 2,625 50.3
>8 669 17.7 226 15.7 895 17.2
Missing information 6 0.2 6 0.4 12 0.2
Skin color/ethnicity
White 1,093 28.9 882 61.3 1,975 37.9 0.000
Mixed 1,531 40.5 204 14.2 1,735 33.2
Black 1,134 30.1 338 23.5 1,472 28.2
Asian/native 13 0.3 11 0.7 24 0.5
Missing information 7 0.2 4 0.3 11 0.2
Familiar income in Brazilian monthly 
minimal wages
≤1 1,182 31.3 401 27.9 1,583 30.3 0.262
>1 and <3 1,260 33.3 450 31.3 1,710 32.8
≥3 1,283 34.0 494 34.3 1,777 34.1
Missing information 53 1.4 94 6.5 147 2.8
Number of prenatal care visits
None 867 23.0 521 36.2 1,388 26.6 0.000
1–3 840 22.2 316 22,0 1,156 22.2
4–6 1,371 36.3 305 21.2 1,676 32.1
≥7 693 18.3 211 14.6 904 17.3
Missing information 7 0.2 86 6.0 93 1.8
Number of previous pregnancies
None 1,051 27.8 268 18.6 1,319 25.3 0.000
1–2 1,684 44.6 625 43.4 2,309 44.3
≥3 1,043 27.6 514 35.8 1,557 29.8
Missing information – – 32 2.2 32 0.6
Number of abortions
None 2,882 76.3 1,146 79.6 4,028 77.2 0.001
1 649 17.2 201 14.0 850 16.3
>1 242 6.4 57 4.0 299 5.7
Missing information 5 0.1 35 2.4 40 0.8
Timing of HIV testing
During labor 1,228 32.5 1,277 88.7 2,505 48.0 0.000
Postpartum 2,550 67.5 155 10.8 2,705 51.8
Missing information – – 7 0.5 7 0.2
Rapid test result
Positive 50 1.3 93 6.5 143 2.7 0.000
Negative 3,726 98.6 1,344 93.4 5,070 97.2
Missing information 2 0.1 2 0.1 4 0.1
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All but one newborn in each city received oral zidovu-
dine. Among the newborns, 27.7% and 68.8% in RJ and 
POA, respectively, were benefi ted from in utero ZDV 
exposure. Complete avoidance of newborn exposure 
to breast milk was possible in 96.8% of the cases in 
POA and 51.1% in RJ while they were in the maternity 
hospital (Table 2).
About 75% of the newborns from those women tested 
during labor received pre- and post-exposure ZDV and 
were not breastfeed during their stay in the maternity 
hospital. One newborn in RJ did not receive any of the 
three recommended PMTCT interventions.
Among the newborns whose mothers were tested in the 
postpartum, 100% in RJ and POA received post-expo-
sure prophylaxis with ZDV. In RJ, 33.3% of newborns 
from women tested in the postpartum period were not 
breastfeed while in the maternity hospital. In POA, none 
of the newborns were breastfeed (Table 2).
Perinatal HIV transmission was confi rmed in 14.6% 
and 11.7% of the newborns in RJ and POA, respec-
tively. Blood samples collected within 48 hours from 
birth for DNA PCR were obtained for 126 newborns 
and in utero transmission of HIV was confi rmed in ten 
newborns, of which four (4/47) in RJ and six (6/79) in 
POA. Two newborns had a positive HIV DNA PCR 
result in the sample collected within 48 hours of birth, 
but their diagnosis could not be confi rmed due to the 
lack of a subsequent sample. Three infants in RJ had an 
undetermined DNA PCR within 48 hours from birth, 
with no subsequent sample for confi rmation. HIV 
infection status could not be determined in 44.4% of 
the infants because they were lost to follow-up early 
during the study.
DISCUSSION
We found a high level of acceptance of HIV rapid 
testing among women admitted for delivery in RJ and 
POA. Similar acceptance rates (98%) were reported 
in RJ14 and India.16 Lower rates were reported in the 
United States by the Miriad study (84.0%)3 and in 
Russia (89.2%).12
Considering the wide availability of PMTCT inter-
ventions in Brazil, the proportion of women contacted 
during this study who reported unknown HIV serostatus 
is unacceptably high (26.3%). Ideally, all women should 
be screened for HIV during an initial prenatal visit. 
Among those enrolled in our study, the overwhelming 
majority had access to prenatal both in RJ and POA, 
with roughly 50% having had four or more visits. In 
spite of this, they were not tested or were unaware of 
their HIV test results.
In the study, 26.6% of women reported no prenatal care. 
For these women, HIV testing during delivery is the 
last opportunity for infants born to them. Although not 
as effective as when started earlier during pregnancy, 
Table 2. Prevention of mother-to-child transmission interventions provided to women and their newborns. Cities of Rio de 
Janeiro and Porto Alegre, Southeastern and Southern Brazil, 2000–2002.
Interventions to the 
newborn – n (%)
Rio de Janeiro Porto Alegre
Total
Labor Postpartum Total Labor Postpartum Total
(n = 17) (n = 30)e,f (n = 47)e,f (n = 86) (n = 7)d (n = 93)d (n = 140)d,e,f
PREP AZTa + NAMb + PEP AZTc 13 (76.5) – 13 (27.7) 64 (74.4) – 64 (68.8) 77 (55.0)
NAM + PEP AZT 1 (5.9) 10 (33.3) 11 (23.4) 18 (20.9) 7 (100.0) 25 (26.9) 36 (25.7)
NAM only – – – 1 (1.2) – 1 (1.1) 1 (0.7)
PEP AZT only 2 (11.8) 20 (66.7) 22 (46.8) 3 (3.5) – 3 (3.2) 25 (17.9)
No intervention 1 (5.9) – 1 (2.1) – – – 1 (0.7)
a PREP ZDV: Pre-exposure prophylaxis with intravenous zidovudine.
b NAM: No breastfeeding while in the maternity hospital.
c PEP ZDV: Post-exposure prophylaxis with oral zidovudine.
d Information regarding PREP ZDV and PEP ZDV were not available for one newborn in Porto Alegre (mother tested during 
labor). This newborn was not included in the table as we could not determine which set of interventions he received 
(missing data).
e Information about breastfeeding while in the maternity hospitals was not available for one newborn in Rio de Janeiro. This 
newborn received PEP AZT (mother tested in the postpartum period). This newborn was not included in the table as we 
could not determine which set of interventions he received (missing data).
f One stillbirth and one newborn who died within a few minutes after birth both in Rio de Janeiro were not included in the 
table.
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clinical trials and observational studies have demons-
trated that short-course interventions administered late 
in pregnancy can reduce MTCT,5,9 even when initiated 
within 48 hours after birth.22
During labor and delivery, intravenous or oral AZT is 
administered as pre- and post-exposure prophylaxis for 
the newborn. Overall, 48% of women in our study were 
tested during labor and 51.8% in the postpartum period. 
A striking difference can be noted between RJ and POA. 
While in POA the majority was tested during labor, in 
RJ most of them were tested in the postpartum. The 
reasons why health teams in POA were most often able 
to test women before delivery than in RJ are out of the 
scope of the present study and we could not identify an 
objective reason for this difference. It should be noted 
that POA sites started the study almost a year later than 
RJ sites when HIV rapid testing was already available 
for regular care in maternity hospitals.
One important aspect in the assessment of the use of 
HIV rapid testing in the delivery setting is to examine 
how feasible the implementation of other PMTCT 
interventions is when a test result is positive. In our 
study, intravenous AZT was administered to 73.1% of 
women tested before delivery. Except for one infant 
for whom this information was missing, all liveborn 
infants of women with a positive test result received 
oral AZT. Regimens that include only intrapartum and 
postpartum drug administration have been shown to be 
effective in reducing perinatal transmission of HIV.13,17 
However, intrapartum pre-exposure prophylaxis alone 
with nucleoside reverse transcriptase inhibitor (NRTIs), 
with no prolonged post-exposure prophylaxis of the 
infant is not effective.17
Knowledge of the mother’s HIV status provides 
opportunities for other effective interventions such 
as formula feeding. In our study, 18.3% of infants 
born to HIV-infected women were breastfeed at least 
for one day, in most cases because the mother’s HIV 
serostatus was only determined in the postpartum. 
This delay in HIV diagnosis unnecessarily exposed 
these infants to the risk of HIV infection. Incremental 
risk of HIV transmission through breastfeeding has 
been estimated to be 14% among chronically infected 
women.8 Dose-response effect of breastfeeding has 
been demonstrated. In a study carried out by the Italian 
Register for HIV Infection11 in children, the adjusted 
infection odds ratio for one day of breastfeeding versus 
exclusive formula feeding was 1.19.11 The probability 
of HIV-1 infection per liter of breast milk ingested by 
an infant is 0.00064, comparable to the risk of trans-
mission through one unprotected act of intercourse 
with an HIV-1-positive individual.18
Available data indicate that without intervention 25% to 
30% of perinatal HIV infection occur in utero.19 In our 
study, ten infants were confi rmed to have been infected 
in utero and two others had a positive HIV DNA PCR 
result in the 48-hour sample, but there was no subse-
quent sample to confi rm this diagnosis. Unfortunately, 
for infants infected in utero, interventions provided 
during labor and delivery are not effective.2
The high proportion of infants lost to follow-up early in 
the study is a matter of concern. The fact that mothers 
and infants were not necessarily followed up in the same 
care service may have contributed to this high rate of lost 
to follow-up. We do not know whether these mothers and 
infants got the care they needed. It points out to the need 
to develop a better referral system for this population 
with tailored outreach strategies.
We found a higher prevalence of HIV infection among 
women enrolled in POA when compared to those in RJ. 
This refl ects the differences on the scope, severity and 
dynamics of the HIV epidemic in south and southeast 
Brazil. A study applying spatial analysis techniques 
using information from AIDS case reporting database 
and liveborn registers found an HIV prevalence of up 
to 8% in some impoverished areas of POA.1
According to the Brazilian Ministry of Health data, 
by the end of 2002, in RJ and POA regions, 52% and 
35% of HIV-infected women, respectively, were not 
identifi ed during pregnancy due to a variety of factors. 
The population of women who were not identifi ed with 
HIV during pregnancy, in POA, may comprise a higher 
proportion of marginalized women with lower or no 
access to prenatal services and highly vulnerable to 
HIV infection when compared to women enrolled in 
RJ sites. The differences found regarding social demo-
graphic data and prenatal care use seen in the study 
population in POA compared to those of the general 
female population supports this hypothesis.
One of the main strengths of our study is its large sample 
size that favors its comprehensiveness, in spite of being a 
convenience sample. The high level of HIV rapid testing 
acceptance among the population studied reinforces the 
generalization of our results on the feasibility of other 
PMTCT interventions in the context of HIV diagnosis 
made during labor and delivery. To the best of our 
knowledge, our study is the largest assessment conducted 
during labor and delivery in Brazil and, so far, the only 
one that assessed the feasibility of other PMTCT inter-
ventions following a positive HIV rapid test result.
Some limitations of the study should be also considered. 
Our fi ndings about acceptance rates may not directly 
refl ect other contexts, such as non-research settings. 
Because patient records from prenatal care are not 
available at maternity hospitals and HIV test results 
are not always recorded on prenatal cards women 
bring to maternity hospitals, we relied on self-reports 
that are potentially subject to response bias and not 
subject to independent verifi cation. We also relied on 
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